|Articles|May 28, 2011

Poll: How often do you recommend the HPV vaccine?

Dr Rebecca B. Perkins and colleagues recently found that the HPV vaccine was not being appropriately offered in a cohort of 136 young, low-income, minority women. The results of their study were presented at the Annual ACOG Meeting in Washington, DC.

Dr Rebecca B. Perkins and colleagues recently found that the HPV vaccine was not being appropriately offered in a cohort of 136 young, low-income, minority women. The results of their study were presented at the Annual ACOG Meeting in Washington, DC.

Poll

Vote in the Poll and share with your colleagues below.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe Now!

Latest CME

Multimedia

Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine

Jessica Ailani, MD, FAHS, FAAN; Paul G. Mathew, MD, DNBPAS, FAAN, FAHS

Poll: How often do you recommend the HPV vaccine?

Newsletter

Related Content

Cynthia Stuenkel, MD, talks evaluating and managing primary ovarian insufficiency

Danette Conklin, PhD, discusses cognitive behavioral therapy for menopausal symptom relief

Elinzanetant demonstrates favorable safety profile in menopausal women, with James A. Simon, MD

FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms

Early natural menopause linked to higher risk of metabolic syndrome

Latest CME

Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine

Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents

Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine

Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances

Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care

Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer

Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Trending on Contemporary OB/GYN

Early estrogen use linked to lower disease risks

FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms

Clinical insights into vulvar health in menopause, with Melissa Mauskar, MD

Caroline Mitchell, MD, highlights safety and flexibility in treating GSM

Postmenopausal women show higher prevalence of dry eye disease